Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 May 2024 | Story ANTHONY MTHEMBU | Photo Supplied
Ibrahim Mahama
Contemporary artist Ibrahim Mahama engaging with students during his visit to the Department of Fine Arts at the University of the Free State (UFS).

Ghanaian contemporary artist, Ibrahim Mahama, visited the Department of Fine Arts at the University of the Free State (UFS) to share insights with staff and students during his stay in the country.

Dr Adelheid Von Maltitz, Senior Lecturer in the Department of Fine Arts at the UFS, highlighted the significance of Mahama’s visit which took place from 21 to 28 March 2024, marking the first instance of such interaction between a Fine Arts department in South Africa and Mahama. She remarked, “It is truly astounding that a person of his calibre dedicated time to focus on our department, and I believe this has catalysed a positive shift within our department.”

Mahama’s impactful presence at UFS

Dr Von Maltitz emphasised that Mahama’s visit aimed to offer staff and students a glimpse into his artistic process and mindset. During his time at the UFS, Mahama, who was virtually overseeing his latest recent large-scale artwork titled Purple Hibiscus, which involved wrapping the Barbican Centre in London, engaged extensively with staff and students from the department about their research. He shared insights into his creative journey, presented select works, and conducted critique sessions with fourth year and postgraduate students, among other activities. Dr Von Maltitz believes this interaction, particularly with students, has significantly bolstered their confidence as aspiring artists, preparing them for professional endeavours.

Broader implications and future prospects

Mahama’s visit not only energised the department’s academic environment but also holds broader implications. Dr Von Maltitz asserted that it will solidify the department’s identity nationally and create avenues for students to pursue residencies in countries like Ghana. Therefore, maintaining a fruitful relationship with Mahama remains a priority for the department.

Reflecting on the visit Dr Von Maltitz concluded, ‘’the key takeaway, especially for the students, was witnessing the potential of their works within the broader South African and international contexts. “ 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept